Cost‐utility of once‐weekly insulin icodec versus once‐daily basal insulins for type 2 diabetes in China

20260 citationsJournal Articlehybrid Open Access

Authors

Abstract

Once-weekly icodec represents a cost-effective and clinically beneficial alternative to once-daily basal insulin analogues for Chinese adults with type 2 diabetes within the current reimbursement framework.

Topics & Keywords

Diabetes Management and Research Hyperglycemia and glycemic control in critically ill and hospitalized patients Diabetes Treatment and Management

UN Sustainable Development Goals

Decent work and economic growth

Publication Details

Published in: Diabetes Obesity and Metabolism

DOI: 10.1111/dom.70567

Field-Weighted Citation Impact: 0.00